Ofev (nintedanib)

pCPA File Number: 20886
Negotiation Status:
Concluded with an LOI
Indication(s):
Idiopathic pulmonary fibrosis (IPF)
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd. Ltee.
CADTH Project Number:
SR0426-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: